Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Treatment Based on Genetic Information Associated With Response to Angiotensin Converting Enzyme Inhibitor

NCT05535595 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT05535595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05535595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Treatment Based on Genetic Information Associated With Response to Angiotensin Converting Enzyme Inhibitor
Lead sponsor
Yonsei University
Phase
Phase 4
Overall status
Completed
Start date
November 6, 2019
Completion date
August 2, 2021
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension